All News

Another case has been settled regarding Johnson & Johnson's Baby Powder and its possible link to ovarian cancer.

A recent study found that gender makes a difference in the survival of a patient with ET.

Selinexor (KPT-330), a small-molecule inhibitor with a novel mechanism of action, is being investigated in patients with multiple myeloma (MM) who have become refractory to the many new options that have been introduced in recent years for patients with the malignancy.

Moving with a health problem comes with the logistical challenge of finding resources in a new place which is a task conquered through patience, kindness and a lot of organization.

The first few weeks after a cancer diagnosis can be scary and confusing.

After being declared cancer-free, Ed found himself back in the doctor's office again.

Eunice Wang, M.D., discusses a promising new drug for the treatment of certain patients with acute myeloid leukemia.

In an interview with CURE, Badani, a professor of Urology at Mount Sinai Hospital, discusses the benefits of robotic surgery in RCC.

Try not to let cancer hinder your career.

Two-time cancer survivor offers help for fatigue, including fatigue that is months and years out from active treatment

Living in fear and worrying about cancer every day is not a way to live. I was given six amazing words of advice that were my wakeup call to get my life after cancer back.

Help us figure out the best, most respectful words to use when discussing cancer.

"I don't think I could breathe without him," said one patient on CURE's Facebook page. See how four-legged friends helped others through their cancer experience.

The treatment paradigm for patients with advanced non-small cell lung cancer (NSCLC) is changing, as more emphasis is being placed on drug combinations and biomarkers, says Roy S. Herbst, M.D., Ph.D.

Finding out you have an illness is quite difficult.

Cancer treatment may seem to involve a mysterious, unfathomable foreign language, but there are ways to improve those lines of communication.

Sometimes powerful, sometimes painful, there are lessons in cancer at every turn.

The designation recognizes that the vaccine, an immunotherapy called SurVaxM, would treat a rare disease, defined as one that affects a patient population of less than 200,000 Americans. However, because it acts on a protein that appears in 80 percent of cancers generally, SurVaxM may have wider applications.

A type of CAR-T cell therapy is showing promise in a phase 1 study for patients with Hodgkin lymphoma and ALCL.

Researchers at Yale compared people who used conventional therapy to those who used only alternative methods

A breast cancer survivor learns to shed her old identity and adapt to her new one.

Appreciating the benefits of radiation, but still hoping for better advancements in an evolving field.

Lynparza tablets (olaparib) tablets were granted FDA approval as a maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.

Besponsa (inotuzumab ozogamicin) was granted FDA approval for certain patients with ALL.

This disconnect can lead to increased burden for caregivers. Researchers from City of Hope National Medical Center in Duarte, California, found that patients view themselves as being more able than their caregivers thought.

It's time to start paying attention to what comes after cancer treatment.

My little yellow dog helped me through cancer and over a year after her death, I still love and miss her--Barbara Tako

Driven by personal experience and his love for art, Ryan Berardi created a 3D animation that would help health care professionals if they wrongly administer chemotherapy to patients.

ASCO updated guidelines for the treatment of certain patients with advanced non-small cell lung cancer (NSCLC).

We are never prepared to hear the words, "You have cancer."